Orient Europharma Co Ltd (4120) — Working Capital to Net Assets Ratio
Orient Europharma Co Ltd (4120) has a Working Capital to Net Assets ratio of 22.1% as of September 2025. Working capital of NT$1.74 Billion (current assets of NT$4.41 Billion minus current liabilities of NT$2.67 Billion) is measured against net assets of NT$7.89 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4120 equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Orient Europharma Co Ltd Working Capital to Net Assets (2015–2024)
This chart shows how Orient Europharma Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the ratio stands at 22.1%, reflecting working capital of NT$1.74 Billion against net assets of NT$7.89 Billion TWD. Check tangible net worth ratio of Orient Europharma Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Orient Europharma Co Ltd (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Orient Europharma Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Orient Europharma Co Ltd (4120) total market value.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 11.5% | NT$667.71 Million | NT$5.82 Billion | NT$3.98 Billion | NT$3.31 Billion | ▼ -0.9 pp |
| 2023 | 12.4% | NT$515.42 Million | NT$4.16 Billion | NT$4.23 Billion | NT$3.71 Billion | ▲ +1.0 pp |
| 2022 | 11.4% | NT$391.79 Million | NT$3.44 Billion | NT$4.19 Billion | NT$3.79 Billion | ▼ -8.7 pp |
| 2021 | 20.1% | NT$693.29 Million | NT$3.45 Billion | NT$3.93 Billion | NT$3.23 Billion | ▼ -28.3 pp |
| 2020 | 48.4% | NT$1.89 Billion | NT$3.91 Billion | NT$4.32 Billion | NT$2.43 Billion | ▲ +1.9 pp |
| 2019 | 46.4% | NT$1.77 Billion | NT$3.81 Billion | NT$4.19 Billion | NT$2.42 Billion | ▼ -7.9 pp |
| 2018 | 54.3% | NT$2.25 Billion | NT$4.14 Billion | NT$3.96 Billion | NT$1.71 Billion | ▲ +10.5 pp |
| 2017 | 43.9% | NT$1.80 Billion | NT$4.10 Billion | NT$3.46 Billion | NT$1.66 Billion | ▼ -12.4 pp |
| 2016 | 56.2% | NT$2.20 Billion | NT$3.92 Billion | NT$3.54 Billion | NT$1.34 Billion | ▲ +10.5 pp |
| 2015 | 45.8% | NT$1.55 Billion | NT$3.38 Billion | NT$2.92 Billion | NT$1.37 Billion | — |